Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Pediatric Brain Tumors Market Be Worth By 2029?

The market for pediatric brain tumors has seen a significant expansion recently. From $1.3 billion in 2024, it is projected to swell to $1.4 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.0%. The substantial growth experienced in the past can be traced back to factors such as the escalating number of pediatric brain tumor cases, burgeoning economies worldwide, increasing investment towards research and development, and a rising demand for diagnostic technologies. Additionally, the incidence of pediatric tumor cases is on a global upswing.

The market of pediatric brain tumors is predicted to witness significant expansion in the forthcoming years, escalating to a whopping $1.81 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 6.8%. Contributing factors to this growth, predicted in the forecast period, encompass precision medicine, molecular profiling, targeted therapy, an enhanced healthcare infrastructure, and broader insurance coverage. Core trends during the forecast period are expected to be innovations in Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and Computed Tomography (CT) scanning technologies, the application of genetic and molecular profiling, the advancement of targeted therapies, the launch of immunotherapies, and the emergence of minimally invasive surgical techniques.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21248&type=smp

What External And Internal Drivers Are Influencing The Pediatric Brain Tumors Market?

The anticipated surge in the pediatric brain tumor market is largely attributed to the rising demand for personalized medicine. This medical approach focuses on tailoring treatments and health decisions based on a person’s unique health needs, lifestyle, and genetic composition. The field of genetic research and improvement in diagnostic tools has significantly enhanced the demand for personalized medicine, paving the way for more efficient and precise treatments. By customizing treatments based on the particular tumor type, mutation and response of the child, personalized medicine enhances results while minimizing side effects. For example, the Personalized Medicine Coalition, a US-based healthcare organization, disclosed that in 2023, the FDA sanctioned 16 new personalized therapy options for patients with rare diseases, marking a significant rise from six in 2022. Hence, the impetus for personalized medicine is fostering the growth of the pediatric brain tumor market.

What Segmentation Insights Are Provided In The Pediatric Brain Tumors Market Research?

The pediatric brain tumorsmarket covered in this report is segmented –

1) By Type: Gliomas; Mixed Neuronal-Glial Tumors; Embryonal Tumors; Choroid Plexus Papilloma Or Carcinoma; Tumors Arising From Non-Neuroepithelial Tissue; Meningeal Tumors

2) By Treatment Type: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Immunotherapy

3) By Diagnosis Method: Imaging Techniques; Biopsy; Neurological Exam; Lumbar Puncture

4) By Age Group: Infants; Toddlers; Children; Adolescents

5) By Application: Hospitals And Clinics; Medical Research Centers; Academic Institutes; Other Applications

Subsegments:

1) By Gliomas: Low-Grade Gliomas; High-Grade Gliomas

2) By Mixed Neuronal-Glial Tumors: Gangliogliomas; Dysembryoplastic Neuroepithelial Tumors (DNET)

3) By Embryonal Tumors: Medulloblastoma; Atypical Teratoid Rhabdoid Tumor (ATRT); Primitive Neuroectodermal Tumors (PNET)

4) By Choroid Plexus Papilloma or Carcinoma: Choroid Plexus Papilloma; Choroid Plexus Carcinoma

5) By Tumors Arising from Non-Neuroepithelial Tissue: Rhabdomyosarcoma; Ewing’s Sarcoma

6) By Meningeal Tumors: Meningiomas; Hemangiopericytomas

Which Trends Are Likely To Redefine Growth Paths In The Pediatric Brain Tumors Market?

Major companies in the pediatric brain tumors market are emphasizing the development of advanced treatments like type II RAF inhibitors to improve targeted therapy and patient outcomes. Type II RAF inhibitors target RAF kinases, particularly mutated forms that drive tumor growth. These inhibitors are designed to block abnormal RAF proteins in certain pediatric low-grade glioma (pLGG) subtypes, disrupting the signaling pathways responsible for tumor cell proliferation and survival. For instance, in April 2024, Day One Biopharmaceuticals, a U.S.-based biotech company, announced that the FDA granted accelerated approval for OJEMDA (tovorafenib) to treat relapsed or refractory pediatric low-grade glioma in patients aged six months and older with specific BRAF alterations. OJEMDA is the first FDA-approved therapy targeting BRAF fusions or mutations in this patient group. This approval is based on a 51% overall response rate from the FIREFLY-1 clinical trial. It is specifically aimed at children whose brain tumors have not responded to previous treatments.

Who Are The Leading Companies Driving The Pediatric Brain Tumors Market?

Major companies operating in the pediatric brain tumors market are AbbVie Inc., Bayer AG, Novartis AG, Roche Holding AG, Takeda Pharmaceutical Company, UCLA Health, Ipsen Pharma, Novocure, Blueprint Medicines, Karyopharm Therapeutics Inc., Renaissance Pharma, Servier Laboratories, Matica Biotechnology, Curis Inc., Oncoheroes Biosciences, Treovir Inc., Plus Therapeutics Inc., Stemline Therapeutics Inc., BrainChild Bio Inc., Seattle Children’s Therapeutics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pediatric-brain-tumors-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Pediatric Brain Tumors Market?

North America was the largest region in the pediatric brain tumors market in 2024. The regions covered in the pediatric brain tumors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21248&type=smp

Browse Through More Reports Similar to the Global Pediatric Brain Tumors Market 2025, By The Business Research Company

Brain Tumor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Brain And Neuroimaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Brain Monitoring Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-monitoring-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model